Announcement on Documents like Prospectus (Registration Draft) for Issuance of Shares to Specific Objects
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
Announcement on Documents like Prospectus (Registration Draft) for Issuance of Shares to Specific Objects
Filed with SSE · · 205 pages · Chinese
Release
Dizal (Jiangsu) Pharmaceutical Co. Ltd. on 6ix
Earlier from Dizal (Jiangsu) Pharmaceutical
- Announcement on Preliminary Earnings Estimate for 2024
- Announcement on Obtaining Registration Approval of Application for Issuance of Shares to Specific Objects by China Securities Regulatory Commission
Later from Dizal (Jiangsu) Pharmaceutical
- Dizal's Golidocitinib in Combination with Anti-PD-1 Shows Promise in IO Resistant Non-Small Cell Lung Cancer
- Announcement on Resolution of the 1st Extraordinary General Meeting in 2025
- Dizal Announces DZD8586 and DZD6008 Presentations at 2025 ASCO Annual Meeting
- Announcement on Correction to the Signing of Agreement on Supervision over Deposit in Special Account for Raised Funds
- Announcement on Voluntary Disclosure of Golidocitinib's Inclusion in the Level-I Recommendation of the CSCO Guidelines for the Diagnosis and Treatment of Lymphoma (2025 Edition)
Follow Dizal (Jiangsu) Pharmaceutical into a list and get an email when it puts out news.
Follow Dizal (Jiangsu) Pharmaceutical